Alexandros Vakalopoulos

USPTO Granted Patents = 51 (Patent Applications = 30)

CIPO Patents = 2 (Patent Applications = 16)

EPO Patents = 44 (Patent Applications = 60)

Average Co-Inventor Count = 8.7

ph-index = 8

Forward Citations = 193(Granted Patents)

Forward Citations (Not Self Cited) = 128(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Hiden, DE (2018)
Hilden, DE (2012 - 2024)

Company Filing History:

26 out of 378

Bayer Pharma Aktiengesellschaft

patents

25 out of 721

Bayer Intellectual Property Gmbh

patents

5 out of 12,164

Bayer Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Pyrazolo Piperidine

S-Alaninate Derivatives

Naphthyridine Carboxylic Acids

Muscarinic M2 Receptor

Imidazo Pyridinecarboxamides

Dicyanopyridines

Aminoindane Derivatives

Triazines

Fused Imidazoles

Dihydropyridine Derivatives

Amino Acid Ester Prodrugs

Aryloxazoles

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195448 - Substituted pyrazolo piperidine carboxylic acids (2025-01-14),

2. 11912692 - Substituted S-alaninate derivatives (2024-02-27),

3. 11472803 - 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof (2022-10-18),

4. 10927109 - 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof (2021-02-23),

5. 10662185 - Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use (2020-05-26),

6. 10519154 - 7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof (2019-12-31),

7. 10435403 - Positive allosteric modulators of muscarinic M2 receptor (2019-10-08),

8. 10292970 - Heteroaryl-substituted imidazo[1,2-A]pyridines and their use (2019-05-21),

9. 10214526 - Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof (2019-02-26),

10. 10174021 - Substituted pyrazolo[1,5-A]pyridines and their use (2019-01-08),

11. 10150773 - N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases (2018-12-11),

12. 10052312 - Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use (2018-08-21),

13. 9776997 - 3-aryl-substituted imidazo[1,2-A]pyridines and their use (2017-10-03),

14. 9771360 - Cyano-substituted imidazo[1,2-A]pyridinecarboxamides and their use (2017-09-26),

15. 9688699 - 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines (2017-06-27),

Title: Inventor Alexandros Vakalopoulos

Introduction: Alexandros Vakalopoulos is a renowned inventor based in Hilden, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Alexandros Vakalopoulos holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Vakalopoulos has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Alexandros Vakalopoulos has collaborated with top engineers, scientists, and designers to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: In conclusion, Alexandros Vakalopoulos continues to push the boundaries of innovation, leaving a lasting legacy in the world of technology and engineering.

This text is generated by artificial intelligence and may not be accurate.